Chronic disease management: a major challenge for the pharmaceutical industry

The pharmaceutical industry in Latin America is currently facing several challenges in terms of containing chronic non-communicable diseases, impacted by the lack of adherence to treatments and the delay in access to innovations in diagnosis, treatment, control and follow-up.

These diseases cause the death of 5.5 million people in the Americas each year, and of these, 2.2 million die before reaching the age of 70, which disproves that they are problems of older people, writes The Pharma Letter's local correspondent.

Cardiovascular diseases constitute the majority of deaths from non-communicable diseases, followed by cancer, respiratory diseases and diabetes.